Development and Validation of a High‐Performance Liquid Chromatography Coupled With Photodiode Array Detection Method for the Simultaneous Analysis of Metformin, Cyanoguanidine, and Antidiabetic Agents in Fixed‐Dose Combinations
Abstract
A novel and reliable high‐performance liquid chromatography coupled with photodiode array (HPLC‐PDA) detection method was developed and validated for the simultaneous determination of metformin hydrochloride, its related impurity cyanoguanidine, and five co‐formulated antidiabetic agents—linagliptin, vildagliptin, sitagliptin, empagliflozin, and dapagliflozin—in pharmaceutical dosage forms. Chromatographic separation was achieved on a PerkinElmer Analytical Cyano column (150 × 4.6 mm, 5 µm) using a gradient elution of 15 mM orthophosphoric acid (containing 5 mM sodium heptane sulfonate) and acetonitrile at a flow rate of 1.0 mL/min. The detection wavelengths were set individually for each analyte (205–228 nm) using a PDA detector. The method was validated according to the International Council for Harmonization Q2(R2) guideline. Linearity was demonstrated within the ranges of 100–600 µg/mL for metformin, 0.2–1.0 µg/mL for cyanoguanidine, 0.25–1.25 µg/mL for linagliptin, 5–30 µg/mL for vildagliptin, 5–30 µg/mL for sitagliptin, and 0.5–3.0 µg/mL for both empagliflozin and dapagliflozin, with correlation coefficients (R
2
) greater than 0.99. Recovery values were between 98% and 102%, and the percentage relative standard deviation values were below 2%, confirming the accuracy, precision, and overall analytical performance. No interference was observed from excipients or blank matrices, and robustness tests confirmed the method's stability under slight variations in analytical…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.